Clinical trial
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial…
NCT00471003 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00471003 |
|---|---|
| Title | The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension |
| Official title | A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients |
| Acronym | METABOLIC |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Pritor (Telmisartan, BAY68-9291) |
| Enrollment | 5,448 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | May 8, 2007 |
| Last update posted | Jan 20, 2010 |
| Countries | Croatia, Poland, Slovakia, Slovenia |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: